Unbearable: Chinese Drugmaker Pulls IPO Over Bear Bile Protests

esilverman A highly controversial initial public offering by a Chinese drugmaker, which uses bile from captive black bears to make medicines for treating the liver and eye, ...

ECRI Institute Launches New User Experience Network for Medical Devices

barbara.lempert First module on CT Scanning Systems includes end-user feedback, market analytics, safety, and recall data ? PLYMOUTH MEETING, Pa., June 6, 2013 /PRNewswire-USNewswire/ ...

Pharmalot… Pharmalittle… Good Morning

esilverman Good morning, everyone, and how are you today? Another shiny day is unfolding over the Pharmalot corporate campus, where the birds are chirping, the dogs are barking, ...

Sentrix Healthcare Communications, April 2013

chris.truelove 230 Park Avenue South, 10th Floor New York, NY 10003 Telephone: 212-771-1300 Sentrix spent 2012 solidifying ongoing relationships and creating new ones. Ongoing situations ...

Star Life Sciences, April 2013

chris.truelove 220 Laurel Road Voorhees, NJ 08043 Telephone: 856-782-7000 Email: info@stargroup1.com Website: stargroup1.com Founded during 2008, Star Life Sciences is a client-centric ...

Topin & Associates Inc, April 2013

chris.truelove 205 North Michigan Avenue, Suite 2315 Chicago, IL 60601 Telephone: 312-645-0100 Email: pepperlogic@topin.com Website: topin.com If you had to, in a single phrase, ...

NIH to Fund Clinical Research Network on Antibacterial Resistance Researchers at Duke University Will Lead the Initiative

barbara.lempert Duke University, Durham, N.C., has been awarded $ 2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the ...

Will FDA Plans To Thwart Superbugs Create A Thorny Conundrum?

esilverman Faced with an urgent need for new antibiotics, the FDA, drugmakers and some lawmakers are take steps to speed development, but the moves are causing controversy. ...

AstraZeneca gets mixed results in Nexium patent fight with Hanmi

Eric Palmer AstraZeneca has gotten mixed results in a lawsuit agreement as it continues to try to hold generics at bay in the U.S. for its blockbuster stomach drug Nexium. It said today ...

A Premature Death? KV Pharma And Makena Make An Unexpected Comeback

esilverman Ever since the scandal erupted over compounding pharmacies and a national outbreak of fungal meningitis, KV Pharmaceuticals has been telling the FDA ‘we told you ...

Study: Avastin Doesn’t Lengthen Survival in Some Brain Cancer Patients

barbara.lempert Drug Doesn’t Lengthen Survival in Some Brain Cancer Patients The drug Avastin combined with chemotherapy and radiation failed to prolong survival in ...

Combo immunotherapies reduce risk of death for melanoma patients

John Carroll FierceBiotech News
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS